In vivo antitumour activity of Britanin against gastric cancer through nuclear factor ‐κB‐mediated immune response

ConclusionsBritanin may be a promising candidate for gastric cancer chemotherapy, and its anticancer effect likely depends on an NF ‐κB‐mediated immune response.

Source: Journal of Pharmacy and Pharmacology - February 13, 2020 Category: Drugs & Pharmacology Authors: Keru Shi, Xinyue Liu, Getao Du, Xiaoxia Cai, Yonghua Zhan Tags: Research Paper Source Type: research